Literature DB >> 15054581

[Therapy of chronic heart failure--carvedilol vs. metoprolol. COMET Study].

G Ertl1, S Nitschmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15054581     DOI: 10.1007/s00108-004-1184-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  5 in total

1.  COMET: a proposed mechanism of action to explain the results and concerns about dose.

Authors:  Ake Hjalmarson; Finn Waagstein
Journal:  Lancet       Date:  2003-09-27       Impact factor: 79.321

2.  COMET: a proposed mechanism of action to explain the results and concerns about dose.

Authors:  J Wikstrand; B Fagerberg; S Goldstein; J Kjekshus; H Wedel
Journal:  Lancet       Date:  2003-09-27       Impact factor: 79.321

3.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

Authors: 
Journal:  Lancet       Date:  1999-06-12       Impact factor: 79.321

4.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

Authors: 
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

5.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

Authors:  Philip A Poole-Wilson; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Peter Hanrath; Michel Komajda; Jacobus Lubsen; Beatrix Lutiger; Marco Metra; Willem J Remme; Christian Torp-Pedersen; Armin Scherhag; Allan Skene
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.